Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 3005

1.

Absorption profiling of cyclosporine microemulsion (neoral) during the first 2 weeks after renal transplantation.

Canadian Neoral Renal Transplantation Study Group.

Transplantation. 2001 Sep 27;72(6):1024-32.

PMID:
11579295
[PubMed - indexed for MEDLINE]
2.

Randomized, international study of cyclosporine microemulsion absorption profiling in renal transplantation with basiliximab immunoprophylaxis.

Internation Neoral Renal Transplantation Study Group.

Am J Transplant. 2002 Feb;2(2):157-66.

PMID:
12099518
[PubMed - indexed for MEDLINE]
Free Article
3.

Cyclosporine microemulsion (Neoral) absorption profiling and sparse-sample predictors during the first 3 months after renal transplantation.

International Neoral Renal Transplantation Study Group..

Am J Transplant. 2002 Feb;2(2):148-56.

PMID:
12099517
[PubMed - indexed for MEDLINE]
Free Article
4.
5.

Longitudinal evaluation of the pharmacokinetics of cyclosporin microemulsion (Neoral) in pediatric renal transplant recipients and assessment of C2 level as a marker for absorption.

Trompeter R, Fitzpatrick M, Hutchinson C, Johnston A.

Pediatr Transplant. 2003 Aug;7(4):282-8.

PMID:
12890006
[PubMed - indexed for MEDLINE]
6.

A randomized, prospective multicenter pharmacoepidemiologic study of cyclosporine microemulsion in stable renal graft recipients. Report of the Canadian Neoral Renal Transplantation Study Group.

Keown P, Landsberg D, Halloran P, Shoker A, Rush D, Jeffery J, Russell D, Stiller C, Muirhead N, Cole E, Paul L, Zaltzman J, Loertscher R, Daloze P, Dandavino R, Boucher A, Handa P, Lawen J, Belitsky P, Parfrey P.

Transplantation. 1996 Dec 27;62(12):1744-52.

PMID:
8990355
[PubMed - indexed for MEDLINE]
8.

Effect of gastrointestinal inflammation and age on the pharmacokinetics of oral microemulsion cyclosporin A in the first month after bone marrow transplantation.

Schultz KR, Nevill TJ, Balshaw RF, Toze CL, Corr T, Currie CJ, Strong DK, Keown PA.

Bone Marrow Transplant. 2000 Sep;26(5):545-51.

PMID:
11019845
[PubMed - indexed for MEDLINE]
Free Article
9.

Association between cyclosporine concentrations at 2 hours post-dose and clinical outcomes in de novo lung transplant recipients.

Akhlaghi F, Gonzalez L, Trull AK.

J Heart Lung Transplant. 2005 Dec;24(12):2120-8. Epub 2005 Oct 3.

PMID:
16364860
[PubMed - indexed for MEDLINE]
10.

[Efficacy of therapeutic monitoring of cyclosporine through C2 and AUC(0-4) during the first 24 months following kidney transplantation].

Vavić N, Ignjatović L, Drasković B, Hrvacević R, Kovacević Z, Paunić Z.

Vojnosanit Pregl. 2008 Feb;65(2):119-27. Serbian.

PMID:
18365668
[PubMed - indexed for MEDLINE]
12.

Peak cyclosporine levels (Cmax) correlate with freedom from liver graft rejection: results of a prospective, randomized comparison of neoral and sandimmune for liver transplantation (NOF-8).

Grant D, Kneteman N, Tchervenkov J, Roy A, Murphy G, Tan A, Hendricks L, Guilbault N, Levy G.

Transplantation. 1999 Apr 27;67(8):1133-7.

PMID:
10232563
[PubMed - indexed for MEDLINE]
13.

Clinical outcomes during the first three months posttransplant in renal allograft recipients managed by C2 monitoring of cyclosporine microemulsion.

Thervet E, Pfeffer P, Scolari MP, Toselli L, Pallardó LM, Chadban S, Pilmore H, Connolly J, Buchler M, Schena FP, Carreño CA, Dandavino R, Cole E.

Transplantation. 2003 Sep 27;76(6):903-8.

PMID:
14508352
[PubMed - indexed for MEDLINE]
14.

Comparison of trough, 2-hour, and limited AUC blood sampling for monitoring cyclosporin (Neoral) at day 7 post-renal transplantation and incidence of rejection in the first month.

Morris RG, Russ GR, Cervelli MJ, Juneja R, McDonald SP, Mathew TH.

Ther Drug Monit. 2002 Aug;24(4):479-86.

PMID:
12142630
[PubMed - indexed for MEDLINE]
15.

Single time point measurement by C2 or C3 is highly predictive in cyclosporine area under the curve estimation immediately after lung transplantation.

Hangler HB, Ruttmann E, Geltner C, Bucher B, Nagiller J, Laufer G, Mueller LC.

Clin Transplant. 2008 Jan-Feb;22(1):35-40. doi: 10.1111/j.1399-0012.2007.00738.x.

PMID:
18217903
[PubMed - indexed for MEDLINE]
16.

Monitoring C2 level predicts exposure in maintenance lung transplant patients receiving the microemulsion formulation of cyclosporine (Neoral).

Jaksch P, Kocher A, Neuhauser P, Sarahrudi K, Seweryn J, Wisser W, Klepetko W.

J Heart Lung Transplant. 2005 Aug;24(8):1076-80.

PMID:
16102443
[PubMed - indexed for MEDLINE]
17.

Cyclosporin A absorption profiles in pediatric renal transplant recipients predict the risk of acute rejection.

Weber LT, Armstrong VW, Shipkova M, Feneberg R, Wiesel M, Mehls O, Zimmerhackl LB, Oellerich M, Tönshoff B; Members of the German Study Group on Pediatric Renal Transplantion.

Ther Drug Monit. 2004 Aug;26(4):415-24.

PMID:
15257072
[PubMed - indexed for MEDLINE]
18.

How to convert from traditional cyclosporine to the microemulsion formulation in stable renal transplant patients?

Gaspari F, Perico N, Pisoni R, Anedda MF, Signorini O, Caruso R, Gotti E, Remuzzi G.

Clin Transplant. 1998 Oct;12(5):379-90.

PMID:
9787945
[PubMed - indexed for MEDLINE]
19.

Pharmacokinetics of oral cyclosporine (Neoral) in heart transplant recipients during the immediate period after surgery.

Banner NR, David OJ, Leaver N, Davis J, Breen J, Johnston A, Yacoub MH.

Transpl Int. 2002 Dec;15(12):649-54. Epub 2002 Nov 22.

PMID:
12478413
[PubMed - indexed for MEDLINE]
20.

[A comparative randomized prospective multicenter study of Sandimmune vs Neoral in liver transplantation].

Roy A, Grant DR, Kneteman NM, Tchervenkov JI, Levy GA, Tan A, Hendricks L.

Ann Chir. 1998;52(8):716-21. French.

PMID:
9846420
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk